ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab

Bernardo Stefanini,1,2 Claudia Angela Maria Fulgenzi,1,3 Bernhard Scheiner,1,4 James Korolewicz,1 Jaekyung Cheon,5 Naoshi Nishida,6 Celina Ang,7 Thomas U Marron,7 Y Linda Wu,8 Anwaar Saeed,9 Brooke Wietharn,10 Lorenza Rimassa,11,12 Angelo Pirozzi,11,12 Antonella Cammarota,12 Tiziana Pressiani,12 Mat...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D'Alessio A
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Online Access:https://www.dovepress.com/albi-grade-enables-risk-stratification-for-bleeding-events-and-refines-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!